(6-Fluoropyridin-2-yl)methanamine hydrochloride

Catalog No.: 
ACNXLU953
CAS No.: 
1423025-98-2
Molecular Formula: 
C6H8ClFN2
Molecular Weight: 
162.60
(6-Fluoropyridin-2-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$155.00In stockInquiry
250mg95%$310.00In stockInquiry
500mg95%$516.00In stockInquiry
1g95%$859.00In stockInquiry
5g95%$2312.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-Fluoropyridin-2-yl)methanamine hydrochloride
IUPAC Name(6-fluoropyridin-2-yl)methanamine hydrochloride
MDL No.MFCD19982295
Molecular FormulaC6H8ClFN2
Molecular Weight162.60
SMILESNCC1=NC(F)=CC=C1.[H]Cl
InChI KeyRDKDGPFKCMEADJ-UHFFFAOYSA-N
Synonym(6-Fluoropyridin-2-yl)methanamine hydrochloride;(6-Fluoropyridin-2-yl)methanamine hydrochloride - [F90274]
CAS No.1423025-98-2
PubChem CID57415796

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNXLU953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACREKW692 route compound structure diagram
    ACREKW6923939-15-9In Stock
  2. Then
  3. ACNXLU953 route product structure diagram
    ACNXLU9531423025-98-2In Stock
Inquiry

2. ACNXLU953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNXLU953 route product structure diagram
    ACNXLU9531423025-98-2In Stock
Inquiry

3. ACNXLU953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNXLU953 route product structure diagram
    ACNXLU9531423025-98-2In Stock
Inquiry

Comments (0)